Basic Materials
Ghcl Limited Reports 12% Q4 Fy26 Profit Growth
GHCL Limited reports 12% profit growth in Q4 FY26. The company’s net revenue increased to Rs. 808 crores.
GHCL Limited announced its financial results for Q4 FY26, showing a 12% increase in Profit After Tax (PAT) compared to Q3 FY26. The company’s net revenue rose to Rs. 808 crores from Rs. 773 crores in the previous quarter.
Strong Domestic Performance
Despite global market volatility, GHCL’s domestic operations have remained resilient. The company’s Managing Director, Mr. R S Jalan, noted that a moderation in import flows has supported the domestic industry, leading to stable demand and improved realizations in India.
Operational Discipline and Cost Optimization
GHCL’s focus on cost optimization, energy efficiency, and process improvements has helped maintain margins. The company’s diversification projects in Bromine and Vacuum Salt are in advanced stages and expected to be commissioned in Q1 of the current financial year.
However, the progress on the greenfield soda ash project has been slower than anticipated. Despite this, GHCL remains committed to aligning capital deployment with evolving market conditions. The company expects domestic demand to remain stable while staying watchful of global developments.
With a strong balance sheet and disciplined execution, GHCL is well-positioned to navigate near-term uncertainties and deliver sustainable long-term value.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of GHCL Limited
GHCL Limited belongs to the Basic Materials › Chemicals sector. Here’s a quick read on where the business and the stock stand today.
GHCL moves sideways over three months, with neither buyers nor sellers taking control. Revenue contracts at 1.3% CAGR. That signals structural headwinds, not a short-term blip. The stock holds at 41% of its 52-week range with RSI at 62. In other words, neither side has a clear edge right now. Revenue grows at 1.3% CAGR and the PEG stands at 99.00. The growth does not match the price the market asks. Furthermore, flat price action adds no technical catalyst. A lower price or faster revenue growth would improve the odds. Check Fundamentals of GHCL Limited.
ANURAS
Anupam Rasayan India Limited Completes Acquisition of Bliss GVS Pharma, Marks Third Strategic Step
Anupam Rasayan India Limited (ANURAS) completes acquisition of Bliss GVS Pharma, marking third strategic step towards building an integrated global pharma pl.
Anupam Rasayan India Limited (BSE: 543275, NSE: ANURAS), one of India’s leading custom synthesis and specialty chemical companies, has concluded the acquisition of a 48.2% controlling stake in Bliss GVS Pharma Limited at ₹299 per share, marking its third strategic inorganic transaction and expanding its presence into finished dosage formulations.
Strategic Milestone
The acquisition, undertaken through Mates Visa Consultancy, a wholly owned subsidiary of Anupam Rasayan, follows the definitive agreement signed on May 23, 2026, and the subsequent completion of the mandatory open offer process. With the acquisition now finalized, Bliss GVS Pharma becomes an integral part of Anupam Rasayan’s expanding portfolio of businesses across specialty chemicals and pharmaceuticals.
Financial and Operational Synergy
The transaction has been funded through a combination of a ₹300 crore term loan and approximately ₹1,450 crore raised through non-controlling, non-voting instruments from a group of financial investors led by Bain Capital and including Trust Group and Investec. The financing structure enables Anupam Rasayan to fund the acquisition while preserving balance-sheet capacity for future growth and expansion.
Future Growth Prospects
On the acquisition, Mr. Anand Desai, Managing Director of Anupam Rasayan India Ltd., said, “We are pleased to announce the successful completion of the acquisition of Bliss GVS Pharma. This transaction marks an important milestone in our long-term strategy to build a diversified, integrated and innovation-led global pharmaceutical platform. The acquisition strengthens our presence in finished pharmaceutical formulations and complements Anupam Rasayan’s expertise in key starting materials, intermediates and specialty chemicals.”
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Anupam Rasayan India Limited
Anupam Rasayan India Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.
Anupam moves sideways over three months, with neither buyers nor sellers taking control. Thin margins at 6.9% leave limited room for error — any demand softness or cost spike hits the bottom line hard. No meaningful dividend — total return is entirely dependent on capital appreciation. Sellers drive 1.8x the volume of buyers. Furthermore, they controlled 17 of recent sessions versus 13 for buyers — a clear distribution signal. Revenue grows at 14.1% yet the PEG reaches 99.00 — expensive for that growth. Furthermore, the stock drops 6.1% in three months. Neither value nor momentum supports this setup. It needs an earnings beat or a price reset first. Check Fundamentals of Anupam Rasayan India Limited.
Aluminum
National Aluminium Company Limited (nationalum) Announces Record Dividend Payment for FY 2025-26
National Aluminium Company Limited (NATIONALUM) pays ₹1,083.06 crore dividend to Government of India for FY 2025-26, marking highest-ever payout.
National Aluminium Company Limited (NATIONALUM) has made headlines today by announcing a record dividend payment of ₹1,083.06 crore to the Government of India for FY 2025-26. This marks the highest-ever dividend paid by the company, reflecting its robust financial performance for the year. The dividend cheque was handed over to Shri G. Kishan Reddy, Hon’ble Union Minister of Coal & Mines, Government of India, during an Investor Roadshow on Angul Aluminium Park held in Kolkata today.
Record-Breaking Dividend
The total dividend paid by NATIONALUM for FY 2025-26 amounts to ₹2,112.12 crore, which includes three interim dividends and a final dividend. This significant payout underscores the company’s commitment to returning value to its shareholders and the government. The robust performance in FY 2025-26 saw a Profit After Tax (PAT) of ₹5,815.76 crore, highlighting the company’s strong financial health and operational efficiency.
Strategic Investment Roadshow
The announcement came during an Investor Roadshow organized by NATIONALUM in association with Odisha Industrial Infrastructure Development Corporation (IDCO) at Angul Aluminium Park in Kolkata. The event aimed to showcase investment opportunities in downstream and value-added aluminium manufacturing. Shri Jagdish Arora, Director (P&T), NATIONALUM, welcomed the attendees and emphasized the investor-friendly ecosystem that supports employment generation and industrial growth.
As a result, the Angul Aluminium Park is poised to become a pivotal platform for establishing and expanding aluminium-based manufacturing operations, fostering innovation, and contributing to India’s vision of building a self-reliant and developed nation.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of National Aluminium Company Limited
National Aluminium Company Limited belongs to the Basic Materials › Aluminum sector. Here’s a quick read on where the business and the stock stand today.
National posts a 2.8% three-month gain, but softens in the last few weeks. The PEG of 0.16 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. Industry-leading margins of 34.9% reflect exceptional pricing power and operational efficiency. The stock gives back 11.6% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. Revenue grows at 7.8% and profits at 59.3%. The business is in good shape. Moreover, a stock that does not move despite strong fundamentals often offers better value than one already priced for perfection. Check Fundamentals of National Aluminium Company Limited.
Basic Materials
Ellenbarrie Industrial Gases Limited Secures ₹481 Crore Air Separation Unit Contract
Ellenbarrie Industrial Gases Limited secures a ₹481 crore contract for a 1200 TPD Air Separation Unit from BHEL for its Coal to Ammonium Nitrate project.
Ellenbarrie Industrial Gases Limited (ELLEN) today announced securing a ₹481 crore contract for a 1200 TPD cryogenic Air Separation Unit (ASU) from Bharat Heavy Electricals Ltd. (BHEL) for its Coal to Ammonium Nitrate (2000TPD) project. This marks a significant milestone for ELLEN as it enters one of India’s largest long-term industrial gas opportunities under the National Coal Gasification Mission. The contract includes design, engineering, supply, erection, testing, pre-commissioning, commissioning, trial runs operation, operator training, demonstration of performance guarantees, supply of spares, and handing over, all on a turnkey basis. The project will be executed over eight quarters and is expected to be commissioned in FY29.
Strategic Project Under National Coal Gasification Mission
This contract is part of India’s broader push towards coal gasification, a strategic national initiative aimed at reducing import dependence while creating domestic production capacity for chemicals, fertilisers, and clean industrial feedstocks. The Government of India has outlined an ambitious vision of gasifying 100 million tonnes of coal annually by 2030, with coal gasification expected to support domestic production of ammonia, urea, methanol, hydrogen, and other downstream chemicals.
Significant Milestone for ELLEN
Commenting on the development, Varun Agarwal, Joint Managing Director of ELLEN, said: ‘This order represents an important strategic milestone for ELLEN as we strengthen our participation in India’s emerging coal gasification ecosystem. While this is a Build and Transfer project, it recognises our capability to deliver large-scale cryogenic Air Separation Units for complex industrial applications. As India’s coal gasification programme gathers momentum over the coming years, we believe our engineering expertise, execution track record, and deep experience in industrial gases position us well to participate in this long-term growth opportunity.’ This contract will be the largest plant built by ELLEN till date and takes the company into an exclusive list of companies having the capability of building plants of more than 1000 TPD.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Ellenbarrie Industrial Gases Limited
Ellenbarrie Industrial Gases Limited belongs to the Basic Materials › Chemicals sector. Here’s a quick read on where the business and the stock stand today.
Ellenbarrie rises 35.6% over three months, with buying pressure holding steady. The PEG of 0.76 signals undervaluation relative to growth. It is a potential re-rating candidate. Industry-leading margins of 33.8% reflect exceptional pricing power and operational efficiency. Buyers show up with 2.2x the volume of sellers. Moreover, they dominated on 17 of recent sessions versus 13 for sellers — a healthy accumulation pattern. Both the business and the stock move in the right direction. Revenue grows at 16.9%, profits at 54.8%, and the PEG sits at 0.76 — below its growth rate. That combination is rare. Check Fundamentals of Ellenbarrie Industrial Gases Limited.
-
Healthcare3 days agoZydus Lifesciences Limited (zyduslife) USFDA Inspection of Pharmacovigilance Concludes with Nil Observations
-
Beverages - Brewers3 days agoSom Distilleries & Breweries Limited (sdbl): Court Judgment Clears Path for Licence Renewal
-
Solar3 days agoSwelect Energy Systems Limited Expands C&I Energy Solutions Portfolio with Rollout of SWEES EN+ Solar Hybrid Inverter Range
-
AUGMONT3 days agoAugmont Enterprises Limited (augmont) Empanelled by NSE for Promotion of Electronic Gold Receipts (EGR)
-
Healthcare22 hours agoLupin Limited (lupin) Receives Tentative FDA Approval for Apixaban Oral Suspension
-
Consumer Defensive22 hours agoRadico Khaitan Limited Expands Global Reach: Indian Luxury Whisky Brands Land in the Home of Scotch
-
Healthcare23 hours agoSun Pharmaceutical Industries Limited (sunpharma) Secures Global Licensing for Lerodalcibep, a PCSK9 Inhibitor
-
Capital Markets22 hours agoIndian Energy Exchange Limited Expands Energy Markets Footprint